Literature DB >> 29692309

Necrotizing Pneumonia Caused by Chromobacterium violaceum: Report of a Rare Human Pathogen Causing Disease in an Immunodeficient Child.

Alean A Frawley1,2, Lauren Powell3, John R McQuiston4, Christopher A Gulvik4, Rodolfo E Bégué5,3.   

Abstract

Chromobacterium violaceum is a rare, potentially serious pathogen. Most clinicians have no experience with its clinical appearance or treatment. We describe a case of a child presenting with necrotizing pneumonia caused by C. violaceum. We describe case complexities, including the need for a multidisciplinary approach to diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29692309      PMCID: PMC6085793          DOI: 10.4269/ajtmh.18-0060

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Fatal infection by Chromobacterium violaceum.

Authors:  P H SNEATH; J P WHELAN; R BHAGWAN SINGH; D EDWARDS
Journal:  Lancet       Date:  1953-08-08       Impact factor: 79.321

Review 2.  Chromobacterium violaceum infection: a clinical review of an important but neglected infection.

Authors:  Ching-Huei Yang; Yi-Hwei Li
Journal:  J Chin Med Assoc       Date:  2011-10-19       Impact factor: 2.743

Review 3.  Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.

Authors:  Maria Chiriaco; Irene Salfa; Gigliola Di Matteo; Paolo Rossi; Andrea Finocchi
Journal:  Pediatr Allergy Immunol       Date:  2016-01-21       Impact factor: 6.377

Review 4.  Necrotizing Pneumonia.

Authors:  Elitsa V Nicolaou; Allison H Bartlett
Journal:  Pediatr Ann       Date:  2017-02-01       Impact factor: 1.132

5.  Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis.

Authors:  R J Mamlok; V Mamlok; G C Mills; C W Daeschner; F C Schmalstieg; D C Anderson
Journal:  J Pediatr       Date:  1987-12       Impact factor: 4.406

6.  The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability.

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-18       Impact factor: 11.205

7.  Isolation of Chromobacterium spp. from foods, soil, and water.

Authors:  J A Koburger; S O May
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

8.  Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum.

Authors:  K E Aldridge; G T Valainis; C V Sanders
Journal:  Diagn Microbiol Infect Dis       Date:  1988-05       Impact factor: 2.803

9.  Chromobacterium Violaceum Sepsis: Rethinking Conventional Therapy to Improve Outcome.

Authors:  Kathleen R Richard; Joshua J Lovvorn; Sara E Oliver; Shannon A Ross; Kim W Benner; Michele Y F Kong
Journal:  Am J Case Rep       Date:  2015-10-19

10.  Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems.

Authors:  Cláudia I Lima-Bittencourt; Spartaco Astolfi-Filho; Edmar Chartone-Souza; Fabrício R Santos; Andréa M A Nascimento
Journal:  BMC Microbiol       Date:  2007-06-21       Impact factor: 3.605

View more
  2 in total

1.  Sepsis in cougar (Puma concolor) associated with Chromobacterium violaceum.

Authors:  Mayara C S R Mesquita; Janaina Marcela A R Moreira; Beatriz S Nogueira; Thais Morgado; Marlon Ribeiro; Edson Moleta Colodel; Luciano Nakazato; Valéria Dutra
Journal:  Braz J Microbiol       Date:  2021-04-07       Impact factor: 2.476

Review 2.  Chromobacterium violaceum: A Review of an Unexpected Scourge.

Authors:  Bachti Alisjahbana; Josephine Debora; Evan Susandi; Guntur Darmawan
Journal:  Int J Gen Med       Date:  2021-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.